Medicover AB (publ)

General ticker "MCVEF" information:

  • Sector: Health Care
  • Industry: Medical - Care Facilities
  • Capitalization: $3.0B (TTM average)

Medicover AB (publ) follows the US Stock Market performance with the rate: 46.7%.

Estimated limits based on current volatility of 0.0%: low 27.25$, high 27.25$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-05-02, amount 0.18$ (Y0.66%)

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [20.62$, 33.73$]
  • 2026-12-31 to 2027-12-31 estimated range: [21.01$, 34.58$]

Financial Metrics affecting the MCVEF estimates:

  • Positive: with PPE of 46.0 at the end of fiscal year the price was neutral
  • Positive: -4.75 < Operating profit margin, % of 6.55
  • Positive: 6.64 < Operating cash flow per share per price, % of 9.84
  • Negative: 0.73 < Interest expense per share per price, % of 1.83
  • Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.10
  • Positive: 19.40 < Shareholder equity ratio, % of 22.01 <= 42.68
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Positive: -9.07 < Industry operating profit margin (median), % of 0.88
  • Positive: Inventory ratio change, % of -0.45 <= 0

Similar symbols

Short-term MCVEF quotes

Long-term MCVEF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €1,746.40MM €2,091.80MM €2,378.10MM
Operating Expenses €1,685.00MM €2,021.50MM €2,222.40MM
Operating Income €61.40MM €70.30MM €155.70MM
Non-Operating Income €-37.80MM €-50.20MM €-57.30MM
Interest Expense €51.40MM €60.52MM €64.00MM
R&D Expense €0.00MM €7.00MM €0.00MM
Income(Loss) €23.60MM €20.10MM €98.40MM
Taxes €5.20MM €5.50MM €25.70MM
Profit(Loss)* €17.60MM €16.70MM €77.50MM
Stockholders Equity €496.50MM €464.80MM €532.80MM
Inventory €59.40MM €69.10MM €67.20MM
Assets €1,941.30MM €2,138.20MM €2,420.90MM
Operating Cash Flow €205.00MM €261.90MM €343.70MM
Capital expenditure €110.50MM €122.30MM €158.10MM
Investing Cash Flow €-119.80MM €-134.70MM €-322.10MM
Financing Cash Flow €-73.70MM €-108.00MM €-5.80MM
Earnings Per Share** €0.12 €0.11 €0.51

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.